The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of phase Ib/II study of durvalumab and guadecitabine in advanced clear cell renal cell carcinoma (ccRCC) and biomarker analysis.
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb/Medarex; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Janssen; Myovant Sciences; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Eric A. Singer
Consulting or Advisory Role - Aura Biosciences; Johnson & Johnson/Janssen; Merck; Vyriad
Research Funding - Astellas Medivation
 
Satwik Acharyya
No Relationships to Disclose
 
Rohan Garje
Research Funding - Amgen (Inst); Endocyte/Advanced Accelerator Applications (Inst); Immunomedics (Inst); Pfizer (Inst); xencor (Inst)
 
Monika Joshi
Consulting or Advisory Role - Seagen
Research Funding - AstraZeneca (Inst); BMS (Inst); Eisai (Inst); Pfizer (Inst)
 
David J. Peace
Stock and Other Ownership Interests - Abbott Laboratories; Bristol-Myers Squibb; Cigna (I); Merck; Pfizer; United Health Group; Vertex
Patents, Royalties, Other Intellectual Property - U.S. Patent # 8,557,777 B2: Methods of Treating Prostate Cancer Using Prostate Specific Antigen and Tumor Endothelial Marker Peptides. October 15, 2013. (Inst)
 
Veera Baladandayuthapani
No Relationships to Disclose
 
Claudia Laancette
No Relationships to Disclose
 
Ilona Kryczek
No Relationships to Disclose
 
Weiping Zou
No Relationships to Disclose
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; BMS; Merck; Pfizer
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Merck